Preview

Pharmacy & Pharmacology

Advanced search

COMPARATIVE STUDY FOR SUBCHRONIC TOXICITY OF VASELINE OIL AND GLYCELAX

https://doi.org/10.19163/2307-9266-2016-4-5-81-89

Abstract

Contemporary therapeutic approaches offer a wide range of laxative agents, which are often used without a control, exceeding the regime recommended. Therefore, the comparative study for subchronic toxicity of both drugs from this group (Vaseline oil and Glycelax) appears interesting.

The aim of the study was the comparison of a toxic influence of 14-days application of the drugs under study.

Methods. The drugs were studied in two doses: higher therapeutic, and toxic, which 10 times exceeds therapeutic dose. We used “Polispektr-8/B” electrocardiograph, BC 2800vet (Mindray) hematologic veterinary analyzer, BS-380 (Mindray) biochemical analyzer, CL-50 urine analyzer. After the animals autopsy we determined organs’ coefficient (heart, lungs, spleen, liver, stomach, kidneys, adrenals).

Results. While studying the ECG of female rats, amplitude of R wave increased after they got Glycelax in both doses. Female rats who got Vaseline oil this index decreased at minimum dose and increased at maximum dose. After Glycelax application, male rats had an increased activity of alanine aminotransferase. After Vaseline oil application at maximum dose, female rats had alkaline phosphatase activity lowered. Female rats, which got a maximum dose of Vaseline oil had a total protein lowered. Glycelax at maximum dose increased the content of bilirubin and its fractions in male and female rats, while Vaseline oil application at maximum dose increased the content of bilirubin in female rats. Male rats which got Glycelax had hemoglobin and hematocrit level increased.

Conclusion. At long-term application of Vaseline oil, animals of both genders had heart disorders with possible development of arrhythmia, hepatotoxic effect, lipid exchange dysfunction. After excessive use of Glycelax the above mentioned is added with possible hemoglobin and rheological blood properties level decrease.

About the Authors

A. V. Voronkov
Pyatigorsk Medical and Pharmaceutical Institute – branch of Volgograd State Medical University of the Ministry of Health of Russia
Russian Federation

Deputy Director for Academic Work, Head of the Chair of Pharmacology with Course of Clinical Pharmacology, Head of the Department of Experimental Pharmacology, Doctor of Medical Sciences,

Pyatigorsk



A. Yu. Terekhov
Pyatigorsk Medical and Pharmaceutical Institute – branch of Volgograd State Medical University of the Ministry of Health of Russia
Russian Federation

Head of the Chair of Pathology, Head of the Laboratory of Drug Safety, Candidate of Pharmaceutical Sciences,

Pyatigorsk



I. N. Dyakova
Pyatigorsk Medical and Pharmaceutical Institute – branch of Volgograd State Medical University of the Ministry of Health of Russia
Russian Federation

Associate Professor of the Chair of Pharmacology with a Course of Clinical Pharmacology, Candidate of Pharmaceutical Sciences,

Pyatigorsk



S. A. Kuleshova
Pyatigorsk Medical and Pharmaceutical Institute – branch of Volgograd State Medical University of the Ministry of Health of Russia
Russian Federation

Assistant Professor of the Chair of Pharmacology with a Course of Clinical Pharmacology. Candidate of Pharmacological Science,

Pyatigorsk



N. S. Avramenko
Pyatigorsk Medical and Pharmaceutical Institute – branch of Volgograd State Medical University of the Ministry of Health of Russia
Russian Federation

Senior Lecturer of the Chair of Pharmacology with a Course of Clinical Pharmacology, Candidate of Pharmacological Sciences,

Pyatigorsk



E. E. Zatsepina
Pyatigorsk Medical and Pharmaceutical Institute – branch of Volgograd State Medical University of the Ministry of Health of Russia
Russian Federation

Senior Lecturer of the Chair of Pharmacology with a Course of Clinical Pharmacology, Candidate of Biological Sciences,

Pyatigorsk



D. I. Pozdnyakov
Pyatigorsk Medical and Pharmaceutical Institute – branch of Volgograd State Medical University of the Ministry of Health of Russia
Russian Federation

Senior Lecturer of the Chair of Pharmacology with a Course of Clinical Pharmacology, Candidate of Biological Sciences,

Pyatigorsk



References

1. Zborovskiy A.B., Tyurenkov I.N., Belousov Y.B. Unfavorable side effects of drugs. Moscow: Medicinal Information Agency, 2008. 656 p.

2. Kornienko E.A. Functional constipationof children. Access mode: http://www.medvestnik.ru/library/article/8025.

3. Osipenko M.F., Livzan M.A. Chronic constipation: from symptoms to diagnosis, and efficient therapy. Algorithm of our actions. Russian medicinal journal. Access mode: http://www.rmj.ru/articles/gastroenterologiya/Hronicheskiy_zapor_ot_simptoma_k_diagnozu_i_effektivnoy_terapii_Algoritm_nashih_deystviy/#ixzz4JgPu9BEl.

4. Guidelines for preclinic studies of drugs, under direction of A.N. Mironov. Moscow: Grif i K, 2012. Vol. 1. 944 p.

5. Guidelines for experimental (preclinic) study for new pharmacological substances. Under reduction of Professor R.U. Khabriev, corresponding member of the Russian Academy of Medical Sciences, 2nd revised and corrected edition. Moscow: Meditsina Publishing House, 2005. 832 p.

6. Nazarenko G.I., Kishkun A.A. Clinical estimation of the laboratory studies results. Moscow: Meditsina, 2000. 157 p.

7. Kishkun A.A. Guidelines for laboratory methods of diagnosis. Moscow: GEOTAR-Media, 2007. 780 p.


Review

For citations:


Voronkov A.V., Terekhov A.Yu., Dyakova I.N., Kuleshova S.A., Avramenko N.S., Zatsepina E.E., Pozdnyakov D.I. COMPARATIVE STUDY FOR SUBCHRONIC TOXICITY OF VASELINE OIL AND GLYCELAX. Pharmacy & Pharmacology. 2016;4(5):81-89. (In Russ.) https://doi.org/10.19163/2307-9266-2016-4-5-81-89

Views: 1172


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2307-9266 (Print)
ISSN 2413-2241 (Online)